Literature DB >> 6289658

Demonstration of the heterozygous state for I-cell disease and pseudo-Hurler polydystrophy by assay of N-acetylglucosaminylphosphotransferase in white blood cells and fibroblasts.

A Varki, M L Reitman, A Vannier, S Kornfeld, J H Grubb, W S Sly.   

Abstract

The biochemical abnormalities of I-cell disease (mucolipidosis II) and pseudo-Hurler polydystrophy (mucolipidosis III) can be explained by a deficiency of the enzyme UDP-N-acetylglucosamine:lysosomal enzyme N-acetylglucosamine-1-phosphotransferase. We demonstrate here that obligate heterozygotes for these autosomal recessive diseases have intermediate levels of this enzymatic activity in homogenates of peripheral blood white cells and in extracts from cultured fibroblasts. This finding provides further evidence that the enzyme deficiency is the primary genetic defect in these diseases. In addition, the previous observation that obligate heterozygotes for mucolipidosis III have elevations of total serum beta-hexosaminidase outside the range of normal was confirmed. In studies of three pedigrees of patients with mucolipidosis III, these techniques were used to score individuals at risk for the carrier state.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6289658      PMCID: PMC1685437     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  28 in total

1.  A hypothesis for I-cell disease: defective hydrolases that do not enter lysosomes.

Authors:  S Hickman; E F Neufeld
Journal:  Biochem Biophys Res Commun       Date:  1972-11-15       Impact factor: 3.575

2.  Genetic heterogeneity in multiple lysosomal hydrolase deficiency.

Authors:  J H Glaser; W H McAlister; W S Sly
Journal:  J Pediatr       Date:  1974-08       Impact factor: 4.406

3.  Beta-glucuronidase deficiency mucopolysaccharidosis: methods for enzymatic diagnosis.

Authors:  J H Glaser; W S Sly
Journal:  J Lab Clin Med       Date:  1973-12

Review 4.  Approaches to the control and prevention of Tay-Sachs disease.

Authors:  M M Kaback; R S Zeiger; L W Reynolds; M Sonneborn
Journal:  Prog Med Genet       Date:  1974

5.  Isoenzymes of serum N-acetyl-beta-D-glucosaminidase in the I cell disease heterozygote.

Authors:  A F Van Elsen; J G Leroy; A L Vercruyssen
Journal:  Hum Genet       Date:  1976-01-28       Impact factor: 4.132

6.  Identification of mannose 6-phosphate in glycoproteins that inhibit the assimilation of beta-galactosidase by fibroblasts.

Authors:  J Distler; V Hieber; G Sahagian; R Schmickel; G W Jourdian
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

7.  Mucolipidosis III (pseudo-Hurler polydystrophy): Clinical and laboratory studies in a series of 12 patients.

Authors:  T E Kelly; G H Thomas; H A Taylor; V A McKusick; W S Sly; J H Glaser; M Robinow; L Luzzatti; C Espiritu; M Feingold; M J Bull; E M Ashenhurst; E J Ives
Journal:  Johns Hopkins Med J       Date:  1975-10

8.  Enzymatic identification of mannose 6-phosphate on the recognition marker for receptor-mediated pinocytosis of beta-glucuronidase by human fibroblasts.

Authors:  M R Natowicz; M M Chi; O H Lowry; W S Sly
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

9.  I-cell disease (mucolipidosis type II). Serum hydrolases in obligate heterozygotes.

Authors:  J G Leroy; A F Van Elsen
Journal:  Humangenetik       Date:  1973

10.  Phosphohexosyl components of a lysosomal enzyme are recognized by pinocytosis receptors on human fibroblasts.

Authors:  A Kaplan; D T Achord; W S Sly
Journal:  Proc Natl Acad Sci U S A       Date:  1977-05       Impact factor: 11.205

View more
  16 in total

1.  Binding receptors for alpha-L-fucosidase in human B-lymphoid cell lines.

Authors:  R A Dicioccio; A L Miller
Journal:  Glycoconj J       Date:  1992-02       Impact factor: 2.916

2.  Properties of N-acetylglucosamine 1-phosphotransferase from human lymphoblasts.

Authors:  L Little; M Alcouloumre; A M Drotar; S Herman; R Robertson; R Y Yeh; A L Miller
Journal:  Biochem J       Date:  1987-11-15       Impact factor: 3.857

3.  Comparative pathology of murine mucolipidosis types II and IIIC.

Authors:  P Vogel; B J Payne; R Read; W-S Lee; C M Gelfman; S Kornfeld
Journal:  Vet Pathol       Date:  2009-03       Impact factor: 2.221

Review 4.  Trafficking of lysosomal enzymes in normal and disease states.

Authors:  S Kornfeld
Journal:  J Clin Invest       Date:  1986-01       Impact factor: 14.808

5.  Five related Lebanese individuals with high plasma lysosomal hydrolases: a new defect in mannose-6-phosphate receptor recognition?

Authors:  D Alexander; G Dudin; F Talj; F Bitar; M Deeb; A Khudr; M Abboud; V M Der Kaloustian
Journal:  Am J Hum Genet       Date:  1984-09       Impact factor: 11.025

6.  Molecular basis of variant pseudo-hurler polydystrophy (mucolipidosis IIIC)

Authors:  A Raas-Rothschild; V Cormier-Daire; M Bao; E Genin; R Salomon; K Brewer; M Zeigler; H Mandel; S Toth; B Roe; A Munnich; W M Canfield
Journal:  J Clin Invest       Date:  2000-03       Impact factor: 14.808

7.  Lysosomal enzyme phosphorylation in human fibroblasts. Kinetic parameters offer a biochemical rationale for two distinct defects in the uridine diphospho-N-acetylglucosamine:lysosomal enzyme precursor N-acetylglucosamine-1-phosphotransferase.

Authors:  L Lang; T Takahashi; J Tang; S Kornfeld
Journal:  J Clin Invest       Date:  1985-12       Impact factor: 14.808

8.  Sandhoff disease heterozygote detection: a component of population screening for Tay-Sachs disease carriers. I. Statistical methods.

Authors:  R M Cantor; J S Lim; C Roy; M M Kaback
Journal:  Am J Hum Genet       Date:  1985-09       Impact factor: 11.025

9.  Nucleotide sequence of rat preputial gland beta-glucuronidase cDNA and in vitro insertion of its encoded polypeptide into microsomal membranes.

Authors:  Y Nishimura; M G Rosenfeld; G Kreibich; U Gubler; D D Sabatini; M Adesnik; R Andy
Journal:  Proc Natl Acad Sci U S A       Date:  1986-10       Impact factor: 11.205

10.  Studies on natural, antibody-dependent, and interleukin-2-activated killer-cell activity of a patient with mucolipidosis III as a test of the mannose-6-phosphate lytic acceptor hypothesis.

Authors:  J A Werkmeister; H F Pross
Journal:  J Clin Immunol       Date:  1985-07       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.